Thomas Malley

Thomas R.
Malley is Chairman at Project C.U.R.E., Inc. He is an Independent Director at Kura Oncology, Inc. since 2015.
He serves as Director at Benevolent Healthcare Foundation.
He is an Independent Director at Kiniksa Pharmaceuticals Ltd. and Kiniksa Pharmaceuticals Corp.
since 2016.
He is an Independent Director at Kiniksa Pharmaceuticals International Plc since 2024.
He is President of Mossrock Capital LLC since 2007.
Formerly, Mr. Malley was Director at Cougar Biotechnology, Inc. from 2007 to 2009.
He was Director at Innovative Acquisitions Corp.
He was on the Board of Directors at Craig Hospital from 2007 to 2013.
He was Director at Janssen Oncology, Inc. from 2007 to 2009.
He was Independent Director at Puma Biotechnology, Inc. from 2011 to 2015.
He was Independent Director at OvaScience, Inc. from 2012 to 2017.
He was Independent Director at Synageva BioPharma Corp.
from 2012 to 2015.
He was Independent Non-Executive Director at BeOne Medicines Ltd. from 2016 to 2024.
He was Executive Vice President at Janus Henderson Investors US LLC from 1991 to 2008.
He was Portfolio Manager at Janus Henderson Global Life Sciences Fund from 1999 to 2007.
Mr. Malley completed undergraduate studies at Stanford University in 1991.